Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota

doi:10.3748/wjg.v29.i27.4236

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 29, Issue 27

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5686)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

114

WORD

HTML

3483

Figures (1-2)

387

Tables (1-5)

546

Sum=4591

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

244

Download

538

Sum=782

Jul 21, 2023 (publication date) through Dec 23, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Jul 21, 2023; 29(27): 4236-4251
Published online Jul 21, 2023. doi: 10.3748/wjg.v29.i27.4236

Table 4 The effect of probiotics on the composition of the gut microbiota in cirrhosis

Probiotic	Taxa that increase in the abundance after the probiotic	Taxa that decrease in the abundance after the probiotic
Lactobacillus acidophilus[159]	Bifidobacterium, Lactobacillus, and Bacteroidaceae	Enterobacteriaceae and Enterococcus
Escherichia coli Nissle 1917[160]	Bifidobacterium and Lactobacillus	Pathogenic enterobacteria
Escherichia coli Nissle 1917[175]	Bifidobacterium and Lactobacillus	Proteus hauseri, Citrobacter, and Morganella
Yakult 400[176]	Clostridium coccoides and Eubacterium cylindroides	Enterobacteriaceae
Lactobacillus GG[177]	Clostridiales Incertae Sedis XIV and Lachnospiracea	Enterobacteriaceae
Bifidobacterium bifidum W23, Bifidobacterium lactis W51, Bifidobacterium lactis W52, Lactobacillus acidophilus W37, Lactobacillus brevis W63, Lactobacillus casei W56, Lactobacillus salivarius W24, Lactococcus lactis W19 and Lactococcus lactis W58[178]	Faecalibacterium prausnitzii, Syntrophococcus sucromutans, Bacteroides vulgatus, Alistipes shahii, and Prevotella

Citation: Maslennikov R, Alieva A, Poluektova E, Zharikov Y, Suslov A, Letyagina Y, Vasileva E, Levshina A, Kozlov E, Ivashkin V. Sarcopenia in cirrhosis: Prospects for therapy targeted to gut microbiota. World J Gastroenterol 2023; 29(27): 4236-4251
URL: https://www.wjgnet.com/1007-9327/full/v29/i27/4236.htm
DOI: https://dx.doi.org/10.3748/wjg.v29.i27.4236